Orthopedics
Reimagined

Monogram is ushering in the future of joint reconstruction. We combine 3D printing and robotics with automated digital image analysis algorithms to enable mass personalization of the next generation of orthopedic implants.

Notice to our investors: We will be unable to meet our April 29, 2020 annual report filing requirements for securities sold pursuant to Tier 2 of Regulation A as a result of circumstances related to COVID-19. As such, we intend to rely on the temporary relief being provided by the Securities and Exchange Commission. We will continue to use our best efforts to comply with our ongoing reporting obligations.

Learn More

Implants that perfectly match every patient

Predictive Algorithms

We start by converting raw 3 dimension imaging into smart CAD models using various computer vision techniques including shape modelling and artificial intelligence (“AI”). Key anatomical landmarks and features are identified to inform the implant design and robotic execution.

Using complex geometric modeling and simulation algorithms we build implants that are optimized restore anatomical function and solve real clinical problems. This is implant design reimagined from the ground up.

3D Printed Implants

Conventional manufacturing techniques require tooling setups that can be labor intensive, time consuming and costly, constraining the possibilities of implant design. By leveraging state-of-the-art manufacturing methods and 3D printing, Monogram will economically deliver highly personalized implants efficiently at scale. New manufacturing methods have enabled new ways of thinking about implant design and allow us to solve real clinical problems in ways that have never been done before.

All Monogram implants will undergo rigorous validations and testing and be manufactured to the highest industry quality standards. Monogram has partnered with companies at the forefront of 3D printing and implant manufacturing to support the development and commercialization of our next generation implants.

Robotic Milling
Cavity Technology

Monogram is taking the capabilities of surgical robotics to the next level. We start with the surgical plan which is run through an optimization and simulation engine to make sure the cuts are being executed as safely and time-efficiently as possible. But we don’t stop there. Rather than relying solely on a pre-operative surgical plan Monogram leverages the kinematic redundancy of the robot to allow for intraoperative obstacle avoidance and real-time tissue tracking. With the ability to simultaneously track 6 objects in real time Monogram allows for the integration of “smart tools” into the surgical theater. What was once an ordinary retractor is now a virtual boundary.

Monogram’s software solution is constantly re-optimizing to real world scenarios. The system is designed for hyper-efficiency down to the fine details. Rather than relying on conventional, cart based optical navigation, Monogram is exploring robot mounted camera systems that eliminate line of site issues and reduce cost and portability issues.

Our goal is to combine state-of-the-art software with world class hardware to deliver a robotic system that addresses the major clinical concerns today – cost, time, and a lack of control or real-time adjustment.

Hip Implant

Monogram utilizes a proprietary design that maximizes contact towards the extremities rather than center. This is inherently more stable.

Utilizing pre-operative image data and 3D printing, Monogram is able to personalize the implants to each patient.

Solving Real Problems

  • For Patients
  • For Surgeons
  • For Hospitals

Every design and development decision at Monogram is focused on the patient and improving clinical outcomes. We want to make patient’s lives better and we think it’s possible.


36%

Survey: 36% of TKA patients would not have undergone the surgery kowing what it did for them (10 years later)


1 in 5

1 in 5 patients are not satisfied with the results of their total knee replacement


Hips

Rate of re-admission: 8%-13%. Approximately 50%-75% are surgical.

Leading preventable surgical re-admission:
  • 21% Dislocation
  • 9.1% Periprosthetic Fracture
  • 8.6% Mechanical Loosening

Knees

Rate of re-admission: 7%-8%.

Leading preventable surgical re-admission:
  • 21% Dislocation
  • 9.1% Periprosthetic Fracture
  • 8.6% Mechanical Loosening
More about Benefits for surgeons

Every design and development decision at Monogram is focused on the patient and improving clinical outcomes. We want to make patient’s lives better and we think it’s possible.


36%

Survey: 36% of TKA patients would not have undergone the surgery kowing what it did for them (10 years later)


1 in 5

1 in 5 patients are not satisfied with the results of their total knee replacement


Hips

Rate of re-admission: 8%-13%. Approximately 50%-75% are surgical.

Leading preventable surgical re-admission:
  • 21% Dislocation
  • 9.1% Periprosthetic Fracture
  • 8.6% Mechanical Loosening

Knees

Rate of re-admission: 7%-8%.

Leading preventable surgical re-admission:
  • 21% Dislocation
  • 9.1% Periprosthetic Fracture
  • 8.6% Mechanical Loosening
More about Benefits for surgeons

Every design and development decision at Monogram is focused on the patient and improving clinical outcomes. We want to make patient’s lives better and we think it’s possible.


36%

Survey: 36% of TKA patients would not have undergone the surgery kowing what it did for them (10 years later)


1 in 5

1 in 5 patients are not satisfied with the results of their total knee replacement


Hips

Rate of re-admission: 8%-13%. Approximately 50%-75% are surgical.

Leading preventable surgical re-admission:
  • 21% Dislocation
  • 9.1% Periprosthetic Fracture
  • 8.6% Mechanical Loosening

Knees

Rate of re-admission: 7%-8%.

Leading preventable surgical re-admission:
  • 21% Dislocation
  • 9.1% Periprosthetic Fracture
  • 8.6% Mechanical Loosening
More about Benefits for surgeons

Meet the Team

Founded by a leading NYC based orthopaedic surgeon and a medtech executive with strong engineering and finance expertise this duo is the face of the future.

More about us

Join the adventure

Monogram is actively fundraising our series-A round with Seedinvest.

More about us

$7M CURRENT INVESTMENT ROUND

$4,648,492 MILLION RAISED

  • 532 Unique Investors
  • $4990 Avg Investment
  • $4 Share Price
  • $1,000 minimum investment